Thyroid disorders are common in young women and may first come to attention when the patient presents for pregnancy care. Various physiologic changes during pregnancy make evaluation of thyroid function during gestation different from that in non-gravid women (see Figure 1 and Table 1.) -thyroid gland enlargement -increased thyroid binding globulins (TBG) -decreased thyroid stimulating hormone (TSH) (changes each trimester) -variable changes in free thyroxine (fT4) (changes each trimester) -increased total thyroxine (tT4) (no change during pregnancy at 7. 5-18.0 mcg/dL) 
HYPERTHYROIDISM
The classic symptoms of Graves' disease are common in pregnant women without thyroid disease and include: palpitations, heat intolerance, weight loss, insomnia, and irritability. (See Table 2 )
The clinical signs of Graves' disease are usually not present in euthyroid pregnant women however. They are usually readily apparent and enable the diagnosis. They include: goiter, exophthalmos, tachycardia at rest, a hyperdynamic precordium, hyperreflexia, and fine tremor.
The complications of untreated severe maternal hyperthyroidism are significant and include: preterm birth, fetal growth restriction, severe preeclampsia, pulmonary edema ("thyroid storm"), and rarely (1-2%) fetal hyperthyroidism.
Diagnosis
The diagnosis can be made by finding: -elevated free T4 and decreased TSH -in combination with the clinical picture ( Table 2) As noted above, TSH may normally be low in pregnancy, and the free thyroxine (fT4) may vary.
An occasional patient may be seen with symptoms of hyperthyroidism and a low TSH, but a normal thyroxine (T4). This may be a spuriously low TSH, but some of these women may have "T3-toxicosis", where only the free triiodothyronine (fT3) will be elevated.
Over 90 percent of women with Graves' disease, an autoimmune disorder, will have thyroid stimulating immunoglobulins (TSI), also known as thyrotropin receptor blocking antibodies (TBII). Documenting their presence or absence will often help make the diagnosis clear (see below about transient thyrotoxicosis and thyroiditis).
Treatment
The treatment of hyperthyroidism in pregnancy is usually with thioamides: propylthiouracil (PTU") or methimazole. These drugs readily cross the placenta, and can cause fetal hypothyroidism, with resultant neurodevelopment impairment. (See Table 3 ) As the fetus is totally dependent on maternal thyroxine until 12-13 weeks gestation, it is better to defer treatment early in pregnancy unless the maternal disease is severe.
Use of thioamides has been associated with agranulocytosis and severe drug-induced hepatitis in young adults. Methimazole is now the recommended first choice drug for hyperthyroidism after the first trimester of pregnancy.
The 2015 ACOG Practice Bulletin points out that methimazole has been associated with fetal esophageal or choana atesia as well as aplasia cutis. The FDA and two major endocrine societies recommend that methimazole only be used after the first trimester.
If the patient has documented severe Graves' disease early in pregnancy, she may be started on PTU and then switched to methimazole after 12 weeks.
Due to the possible fetal effects, these two medications should be used at the lowest dose, keeping the free T4 at the upper limit of normal. Free T4, fetal growth and maternal heart rate should be measured every 4 weeks in women with documented hyperthyroidism. If no complications develop, they do not necessarily need to be delivered early.
After any change in dose, please obtain a free T4 one month later to evaluate the medication changes effect.
Postpartum, women with hyperthyroidism should receive a TSH and free T4 at 6 weeks postpartum. They should be referred to Endocrinology for follow up and consideration for definitive treatment with radioiodine thyroid ablation.
THYROID STORM
Thyroid storm is a medical emergency that occurs in 1% to 2% of pregnancies complicated by hyperthyroidism. Patients with severe and life-threatening thyrotoxicosis typically have an exaggeration of the usual symptoms of hyperthyroidism.
Cardiovascular symptoms include tachycardia to rates that can exceed 140 beats/min, along with congestive heart failure in many patients. Hyperpyrexia to 104 to 106ºF is common. Agitation, delirium, psychosis, stupor, or coma are common and are considered by many to be essential to the diagnosis. Severe nausea, vomiting, or diarrhea, and hepatic failure with jaundice can also occur.
Although thyroid storm can develop in patients with long-standing untreated hyperthyroidism, precipitating factors include infection, preeclampsia, labor and delivery, trauma, and nonthyroidal surgery.
See Appendix 1: Treatment of Thyroid Storm in Pregnant Women

HYPEREMESIS GRAVIDARUM AND GESTATIONAL TRANSIENT THYROTOXICOSIS
While vomiting is not a common symptom of hyperthyroidism, the accompanying weight loss and tachycardia seen with severe nausea and vomiting of early pregnancy may suggest Graves' disease. hCG, which is a weak thyroid stimulator, may cause transient subclinical hyperthyroidism.
Likewise, up to two thirds of women diagnosed with hyperemesis have laboratory evidence of mild hyperthyroidism, most commonly with -a very low TSH and -borderline high free T4
Their physical exam however will usually have no findings to suggest Graves' disease, and borderline high free T4. They will not be found to have thyroid stimulating immunoglobulins (TSI) detected.
Since the fetus is completely dependent on maternal thyroid hormones up until 12-13 weeks gestation, treating this "pseudo-hyperthyroidism" with thioamides can result in adverse fetal consequences, and is to be avoided. ACOG recommends against testing for thyroid function in women with hyperemesis. If doubt exists, repeat a free T4 at 18-20 weeks.
HYPOTHYROIDISM
The symptoms of normal pregnancy, lassitude, weight gain, and constipation, may suggest thyroid deficiency. Physical exam will usually be normal in women with hypothyroidism. (See Table 2 )
Diagnosis
Finding a high TSH and a low free T4 will confirms the diagnosis. Untreated maternal hypothyroidism has been well documented to result in neurodevelopmental problems in their children.
Treatment
In women with known preexisting hypothyroidism, thyroxine requirements usually go up in pregnancy. As soon as possible, their usual dose should be increased by 50 mcg to meet fetal needs, e.g., if a woman was on 100 mcg of levothyroxine prior to pregnancy, her dose may be empirically increased to 150 mcg when pregnancy is diagnosed. TSH should be checked each trimester. Changes in dose take at least 4-6 weeks to be reflected in laboratory results. (See Table 3 )
Subclinical hypothyroidism ACOG does not currently recommend universal TSH screening in pregnant women in order to diagnosis subclinical hypothyroidism, although this subject remains controversial. ACOG also does not recommend treatment. (See Table 3 )
THYROIDITIS
The majority of new cases of hypothyroidism diagnosed during pregnancy are a result of Hashimoto's disease (chronic autoimmune thyroiditis). Physical findings are usually normal. Subacute lymphocytic thyroiditis is more common postpartum, and an enlarged tender gland is usually found. In Hashimoto's disease, there may be an initial transient hyperthyroid phase, which can cause diagnostic confusion with Graves' disease.
Diagnosis
The diagnosis of Hashimoto's disease is fairly straightforward, as over 90% of cases will have elevated levels of anti-thyroid peroxidase antibodies (also known as antimicrosomal antibodies). Even if in they are in the hyperthyroid phase, unlike Graves' disease patients, they will not have thyroid stimulating immunoglobulins present. Testing for thyroid antibodies is usually not necessary, but may be very helpful where clinical doubt about the diagnosis exists.
Treatment
See hypothyroid therapy above. As soon as possible, their usual dose should be increased by 50 mcg to meet fetal needs. TSH should be checked each trimester. Changes in dose take at least 4-6 weeks to be reflected in laboratory results.
THYROID NODULES
-Young women represent a significant proportion of cases of thyroid cancer.
-Solitary thyroid nodules are often first discovered during pregnancy, and may be malignant in up to 40% of cases.
-Pregnancy is not thought to impact the outcome of this type of cancer.
Diagnosis
Palpable nodules should be further investigated with ultrasound. This may characterize nodules as solid, cystic, or mixed, but cannot differentiate benign from malignant nodules. Ultrasound guided fine needle aspiration is indicated, but excision may be necessary to establish a definitive diagnosis.
Treatment
Current evidence does not demonstrate that thyroxine suppressive therapy of benign nodules or cysts is effective. Definitive therapy is postponed till the postpartum period.
Clinical Pearls
Use TSH to monitor hypothyroidism Use free T4 to monitor hyperthyroidism Do not order 'Thyroid function studies' in routine hyperemesis
Check appropriate lab tests 4 weeks after making any medication changes (free T4 for hyperthyroidism and TSH for hypothyroidism)
No need to treat subclinical hypothyroidism 
